Cell death decision by p53 via control of the mitochondrial membrane

Cancer Letters

Volumn 367, Issue 2, 2015, Pages 108-112

  Dashzeveg, Nurmaa ^a   Yoshida, Kiyotsugu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Mitochondria; Necroptosis; Necrosis; P53

Indexed keywords

CYCLOPHILIN D; DYNAMIN RELATED PROTEIN 1; MICRORNA; MITOCHONDRIAL PROTEIN; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN MCL 1; PROTEIN MDM2; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN;

APOPTOSIS; CANCER RESISTANCE; CELL DEATH; CELL HYPOXIA; COMPLEX FORMATION; DNA DAMAGE; HUMAN; MEMBRANE BIOLOGY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION; MITOCHONDRIAL PERMEABILITY; NECROPTOSIS; NONHUMAN; OXIDATIVE STRESS; PERMEABILITY TRANSITION PORE OPENING; PRIORITY JOURNAL; PROTEIN PROCESSING; SHORT SURVEY; TRANSCRIPTION REGULATION; ANIMAL; GENETICS; METABOLISM; MITOCHONDRION; MUTATION; NECROSIS; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; MUTATION; NECROSIS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84939266852     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.07.019     Document Type: Review

References (61)

1. Spierings D., et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 2005, 310(5745):66-67.
2. Matoba S., et al. p53 regulates mitochondrial respiration. Science 2006, 312(5780):1650-1653.
3. Saleem A., et al. Effect of p53 on mitochondrial morphology, import and assembly in skeletal muscle. Am. J. Physiol. Cell Physiol 2015, 308(4):C319-C329.
4. Marshall K.D., Baines C.P. Necroptosis: is there a role for mitochondria?. Front. Physiol 2014, 5:323.
5. Kinnally K.W., et al. Is mPTP the gatekeeper for necrosis, apoptosis, or both?. Biochim. Biophys. Acta 2011, 1813(4):616-622.
6. Jiang L., et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 2015, 520(7545):57-62.
7. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 2001, 7(3):683-694.
8. Wei M.C., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292(5517):727-730.
9. Matsuda K., et al. p53AIP1 regulates the mitochondrial apoptotic pathway. Cancer Res 2002, 62(10):2883-2889.
10. Mihara M., et al. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11(3):577-590.
11. Chipuk J.E., et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303(5660):1010-1014.
12. Leu J.I., et al. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol 2004, 6(5):443-450.
13. Chipuk J.E., et al. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005, 309(5741):1732-1735.
14. Marchenko N.D., et al. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 2007, 26(4):923-934.
15. Chipuk J.E., Green D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?. Trends Cell Biol 2008, 18(4):157-164.
16. Chipuk J.E., Green D.R. PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis. Cell Cycle 2009, 8(17):2692-2696.
17. Hagn F., et al. BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J. Biol. Chem 2010, 285(5):3439-3450.
18. Follis A.V., et al. The DNA-binding domain mediates both nuclear and cytosolic functions of p53. Nat. Struct. Mol. Biol 2014, 21(6):535-543.
19. Vandenabeele P., et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol 2010, 11(10):700-714.
20. Christofferson D.E., Yuan J. Necroptosis as an alternative form of programmed cell death. Curr. Opin. Cell Biol 2010, 22(2):263-268.
21. Wang Z., et al. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012, 148(1-2):228-243.
22. Vaseva A.V., et al. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 2012, 149(7):1536-1548.
23. Pei L., et al. DAPK1-p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death. J. Neurosci 2014, 34(19):6546-6556.
24. Wang J.X., et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med 2010, 17(1):71-78.
25. Li J., et al. miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet 2010, 6(1):e1000795.
26. Guo X., Sesaki H., Qi X. Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo. Biochem. J. 2014, 461(1):137-146.
27. Yagoda N., et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 2007, 447(7146):864-868.
28. Dixon S.J., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012, 149(5):1060-1072.
29. Li P.F., Dietz R., von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 1999, 18(21):6027-6036.
30. Moll U.M., Marchenko N., Zhang X.K. p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene 2006, 25(34):4725-4743.
31. Chipuk J.E., et al. The BCL-2 family reunion. Mol. Cell 2010, 37(3):299-310.
32. Graupner V., et al. Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level. Cell Death Differ 2011, 18(7):1130-1139.
33. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80(2):293-299.
34. Oda E., et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288(5468):1053-1058.
35. Shibue T., et al. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 2003, 17(18):2233-2238.
36. Tomita Y., et al. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem 2006, 281(13):8600-8606.
37. Karbowski M., et al. Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006, 443(7112):658-662.
38. Chi S.W. Structural insights into the transcription-independent apoptotic pathway of p53. BMB Rep 2014, 47(3):167-172.
39. Miyashita T., et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9(6):1799-1805.
40. Cimmino A., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(39):13944-13949.
41. Xia L., et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 2008, 123(2):372-379.
42. Zhu W., et al. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer 2010, 127(11):2520-2529.
43. Xu K., et al. miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells. Mol. Carcinog 2011, 52(1):70-78.
44. Zhu W., et al. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother. Pharmacol 2011, 69(3):723-731.
45. Nakazawa K., Dashzeveg N., Yoshida K. Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage. FEBS J. 2014, 281(13):2937-2944.
46. Taira N., et al. Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 2014, 111(2):717-722.
47. Wang X., et al. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull 2009, 80(4-5):268-273.
48. Bommer G.T., et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol 2007, 17(15):1298-1307.
49. Lin X., et al. Downregulation of Bcl-2 expression by miR-34a mediates palmitate-induced Min6 cells apoptosis. J. Diabetes Res 2014, 2014. 258695.
50. Suzuki H.I., et al. Modulation of microRNA processing by p53. Nature 2009, 460(7254):529-533.
51. Follis A.V., et al. PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis. Nat. Chem. Biol 2013, 9(3):163-168.
52. Erster S., et al. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell. Biol 2004, 24(15):6728-6741.
53. Oltersdorf T., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005, 435(7042):677-681.
54. Riley T., et al. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol 2008, 9(5):402-412.
55. Sax J.K., et al. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol 2002, 4(11):842-849.
56. Dashzeveg N., et al. Palmdelphin, a novel target of p53 with Ser46 phosphorylation, controls cell death in response to DNA damage. Cell Death Dis 2014, 5:e1221.
57. Vanlangenakker N., et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 2011, 18(4):656-665.
58. Ardestani S., Deskins D.L., Young P.P. Membrane TNF-alpha-activated programmed necrosis is mediated by Ceramide-induced reactive oxygen species. J. Mol. Signal 2013, 8(1):12.
59. Green D.R., Galluzzi L., Kroemer G. Cell biology. Metabolic control of cell death. Science 2014, 345(6203). 1250256.
60. Kim M., et al. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Cancer Res 2004, 64(12):4078-4081.
61. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2(1):38-47.